Abstract
The responsibilities of sponsors, clinical investigators, and institutional review boards (IRBs) in the conduct of clinical research are summarized and some of the problems which each of these parties has experienced in the conduct of clinical research are described. The paper concludes with specific recommendations to secure appropriate relationships among sponsors, clinical investigators, and IRBs.
Get full access to this article
View all access options for this article.